Where human lines dominate basic biology, the rodent and primate lines below dominate two other jobs: modelling disease in a syngeneic animal, and manufacturing or amplifying biologics. This second catalogue covers the mouse, hamster, and monkey lines most often paired with the human set — with the same emphasis on origin, why the line exists, and what it cannot do.
L929 (mouse fibroblast)
- Species/tissue: Mus musculus, connective-tissue fibroblast; the "L" line was established by Wilton Earle in the 1940s from mouse fibroblasts, and L929 is a well-known subclone.
- Origin: one of the earliest continuous mammalian cell lines; derived from normal mouse fibroblasts that acquired malignant potential in long-term culture. Murine, adherent, and very robust.
- Growth: adherent, fibroblast-like, DMEM or MEM + 10% FBS. Grows to high density and is tolerant of poor handling.
- Typical uses: cytotoxicity and biocompatibility testing (the standard "normal" comparator to tumour lines), mouse cell transfection controls, cytokine/bioassay work, and TNF sensitivity assays. In nanoparticle work it serves as a non-tumour mouse line alongside human HEK293T.
- Caveats: the line is not truly "normal" — it is a long-established, karyotypically altered line with a transformed phenotype, so a difference versus a tumour line is not proof of tumour-specific toxicity. It is also very sensitive to some cytokines, which can confound viability readouts.
4T1 (mouse mammary carcinoma)
- Species/tissue: Mus musculus (BALB/c), mammary gland carcinoma.
- Origin: a 4T1 line derived from a spontaneously arising BALB/c mammary tumour; syngeneic to BALB/c mice, which is its defining advantage.
- Growth: adherent, epithelial-like, RPMI-1640 or DMEM + 10% FBS. Grows well in vitro and as orthotopic tumours in vivo.
- Typical uses: the standard syngeneic breast-cancer metastasis model. Because it is BALB/c-syngeneic, it can be implanted into immunocompetent mice without rejection — essential for studying immune involvement. Bioluminescent 4T1-luc derivatives allow non-invasive tumour tracking by D-luciferin imaging.
- Caveats: luciferase expression can impose a metabolic burden and does not report necrotic tissue, so bioluminescence and caliper measurements should be interpreted together. Metastasis patterns vary with injection site (orthotopic vs tail-vein vs subcutaneous), so state which step of metastasis a model reports.
NIH3T3 (mouse embryonic fibroblast)
- Species/tissue: Mus musculus, NIH Swiss mouse embryo fibroblast.
- Origin: a contact-inhibited, non-tumorigenic mouse fibroblast line established at the NIH; the "3T3" refers to the 3-day transfer, 3 × 105 cells protocol used to derive it.
- Growth: adherent, fibroblast-like, DMEM + 10% FBS; contact-inhibited so it forms orderly monolayers.
- Typical uses: transformation and oncogene studies, cell-cycle and contact-inhibition experiments, and as a classic transfection/expression host. Its untransformed phenotype makes it a useful contrast to cancer lines.
- Caveats: it is not diploid or genetically pristine; multiple subclones circulate and behave differently. Because it is contact-inhibited, confluence-based assays need careful growth-state control.
CHO (Chinese hamster ovary)
- Species/tissue: Cricetulus griseus, ovary; the parental CHO line was isolated by Puck and colleagues in 1958.
- Origin: an immortalised, near-diploid hamster line with a rapid growth rate and a very high capacity for protein secretion. Its descendants (CHO-K1, CHO-DG44, CHO-S, and others) are the industrial standard for biopharmaceutical production.
- Growth: adherent (CHO-K1) or suspension-adapted (CHO-S); serum-free, chemically defined media are routine at manufacturing scale. Robust and scalable.
- Typical uses: production of recombinant antibodies and Fc-fusion proteins (the platform behind most therapeutic monoclonal antibodies), stable cell-line generation via DHFR or GS selection, and glycosylation engineering.
- Caveats: CHO glycosylation differs from human — notably α-Gal and Neu5Gc epitopes can be immunogenic — so glycan analysis is part of any therapeutic workflow. Productivity varies hugely between subclones, so screening is essential.
COS-7 (monkey kidney)
- Species/tissue: Chlorocebus sabaeus (African green monkey), kidney; derived from CV-1 cells and described by Gluzman in 1981.
- Origin: CV-1 cells transformed with an origin-defective SV40 genome, so COS-7 constitutively expresses SV40 large T antigen.
- Growth: adherent, fibroblast-like, DMEM + 10% FBS.
- Typical uses: high-level transient expression of SV40-origin vectors (the same large-T trick as HEK293T, in a monkey cell), and as the classic reference for primate cell physiology and virus studies.
- Caveats: like any large-T line, p53/Rb pathways are perturbed, so it is not a normal cell-cycle model. Large-T support can also drive replication of co-transfected SV40-origin plasmids and confound plasmid-based assays.
Vero (monkey kidney)
- Species/tissue: Chlorocebus sabaeus, kidney; established in 1962 by Yasumura and Kawakita (the name derives from "verda reno," Esperanto for "green kidney").
- Origin: a continuous, interferon-deficient monkey kidney epithelial line — the deficiency is the key property.
- Growth: adherent epithelial, DMEM or MEM + 5–10% FBS; forms confluent monolayers suitable for plaque assays.
- Typical uses: virus propagation, titration and plaque assays, vaccine production (Vero cells are WHO-approved for vaccine manufacture), and toxicity testing. The defective interferon response makes them highly permissive to many viruses.
- Caveats: the interferon deficiency means Vero cells are a poor model for antiviral immunity. Their genome has been characterised and shows rearrangements, so do not assume a normal karyotype.
Pairing lines across species
A frequent design is a human tumour line plus a mouse "normal" line, or a syngeneic mouse pair. Two rules keep such comparisons honest:
- Match the transformation status, not just the species. Comparing a primary-like line to a long-passaged one confounds species with transformation.
- Confirm species identity. Rodent and primate lines cross-contaminate just as human ones do; STR (human) and species-specific markers catch it.
References
- Earle WR, Schilling EL, Stark TH, et al. Production of malignancy in vitro. IV. The mouse fibroblast cultures and changes seen in the living cells. J Natl Cancer Inst. 1943;4(2):165–212. doi:10.1093/jnci/4.2.165
- Aslakson CJ, McEachern D, Conaway DH, Miller FR. Inhibition of lung colonization at two different steps in the metastatic sequence. Clin Exp Metastasis. 1991;9(2):139–150. doi:10.1007/bf01756385
- Puck TT, Cieciura SJ, Robinson A. Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects. J Exp Med. 1958;108(6):945–956. doi:10.1084/jem.108.6.945
- Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 1981;23(1):175–182. doi:10.1016/0092-8674(81)90282-8
- Osada N, Kohara A, Yamaji T, et al. The genome landscape of the African green monkey kidney-derived Vero cell line. DNA Res. 2014;21(6):673–683. doi:10.1093/dnares/dsu029
- Baklaushev VP, Kilpeläinen A, Petkov S, et al. Luciferase expression allows bioluminescence imaging but imposes limitations on the orthotopic mouse (4T1) model of breast cancer. Sci Rep. 2017;7:7715. doi:10.1038/s41598-017-07851-z